Table 1 Demographics and baseline characteristics of patients (n = 32)
From: The impairment of small nerve fibers in severe sepsis and septic shock
Parameter Statistic | |
|---|---|
Sociodemographic data | |
Age, years, median, mean (IQR) | 69, 67.41 (61.50–77.25) |
Male gender, number (%) | 19 (59.4) |
Body mass index, kg/m2, mean ± SD | 27.50 ± 5.04 |
Clinical data | |
APACHE II scorea, mean ± SD | 23.38 ± 5.73 |
Septic shock, number (%) | 25 (78.1) |
History of diabetes, number (%) | 13 (40.6) |
Heart failure, number (%) | 5 (15.6) |
Cerebrovascular disease, number (%) | 15 (46.9) |
Renal dysfunction, number (%) | 3 (9.4) |
Chronic obstructive pulmonary disease, number (%) | 4 (12.5) |
Liver cirrhosis, number (%) | 0 (0.0) |
History of cancerb, number (%) | 2 (6.3) |
Immunosuppressionc, number (%) | 4 (12.5) |
Recent surgical history | |
Elective surgery, number (%) | 2 (6.3) |
Emergency surgery, number (%) | 8 (25.0) |
No history of surgery, number (%) | 22 (68.8) |
Site of infection (multiple responses per patient possible) | |
Pneumonia, number (%) | 20 (62.5) |
Other respiratory tract, number (%) | 3 (9.4) |
Intraabdominal/gastrointestinal, number (%) | 6 (18.8) |
Bones/soft tissue, number (%) | 0 (0.0) |
Surgical wound infection, number (%) | 0 (0.0) |
Urogenital, number (%) | 1 (3.1) |
Primary bacteremia, number (%) | 1 (3.1) |
Cardiovascular, number (%) | 1 (3.1) |
Others (central nervous system, thoracal, catheter, etc.), number (%) | 4 (12.5) |
Source of infection | |
Community acquired, number (%) | 9 (28.1) |
Nosocomial, number (%) | 23 (71.9) |
Infection | |
Microbiologically confirmed, number (%) | 27 (84.4) |
Clinical evidence, number (%) | 5 (15.6) |
Mortality, length of stay, mechanical ventilation, renal replacement | |
ICU mortality, number (%) | 2 (6.3) |
Hospital mortality, number (%) (95 % CI) | 5 (15.6) (6.86; 31.75) |
Length of stay on ICU, calendar days, median (IQR) | 24.5 (17–30.25) |
Length of stay in hospital, calendar days, median (IQR) | 29 (24–48.5) |
Mechanical ventilation, number (%) | 31 (96.9) |
Days with mechanical ventilationd, median (IQR) | 20.5 (14–29) |
Renal replacement therapy, number (%) | 5 (15.6) |
Days with renal replacement therapy, median (IQR) | 18 (18–20) |